Navigation Links
Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding
Date:2/11/2008

KENSINGTON, Md., Feb. 11 /PRNewswire-USNewswire/ -- "Psoriasis Cure Now," a nonprofit patient advocacy group, today applauded Congress and the National Institutes of Health (NIH) for delivering a record $10 million in psoriasis research funding during fiscal year 2007. Psoriasis research has traditionally been underfunded at NIH. Since 1995, NIH funding on other diseases has risen 159% (before inflation), but psoriasis and psoriatic arthritis research had been stuck between $5 and $6 million every year from FY 1995 until FY 2006, when it reached $8 million, and now $10 million in FY 2007.

"Psoriasis Cure Now was founded in 2005 because it was disturbing to see psoriasis research funding not even keep pace with inflation as research on other diseases more than doubled," said Michael Paranzino, president of Psoriasis Cure Now. "We are thrilled to see Congress and NIH working to reverse this funding shortfall with the second significant funding increase in a row."

Even after two years of strong growth, psoriasis research at NIH remains $40 million short of what would have been invested in psoriasis research had its funding merely kept pace with NIH's growth since 1995. Psoriasis Cure Now has urged policymakers to increase annual psoriasis and psoriatic arthritis research to $20 million by 2010, reflecting the disease's severe impact on millions of Americans and the years that were lost as psoriasis funding languished.

"Many people helped get funding for psoriasis research moving in the right direction," Paranzino added, "from the citizens who wrote letters to and visited with their lawmakers, to leaders like Reps. Rosa DeLauro, Ralph Regula and Jim Gerlach, Chairmen Tom Harkin and David Obey, and Senator Arlen Specter. The NIH and NIAMS leadership also deserve our thanks for supporting valuable research that will lead to treatment breakthroughs in the years ahead. With new research linking psoriasis to increased risk of heart attack and even
'/>"/>

SOURCE Psoriasis Cure Now
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
2. Americas Next Top Model Steps up for Psoriasis Awareness
3. Chicagoland Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
4. Psoriasis Cure Now Rolls Out First National Short Sleeve Day Saturday
5. DC Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
6. Salt Lake City Psoriasis Event Saturday Will Celebrate First National Short Sleeve Day
7. San Francisco Psoriasis Event Tonight Will Celebrate First National Short Sleeve Day
8. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
9. National Psoriasis Foundation Marks World Psoriasis Day With Call to Support Psoriasis Legislation
10. New study shows smoking increases risk of psoriasis
11. $6.37 million from National Institutes of Health to find new ways to treat psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2IPY follow up requires year round research on Arctic and global warming 9894 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 3Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 4Schofield Media Names Brian Reshefsky Group President 56972 1